HK1206031A1 - 抗菌化合物 - Google Patents
抗菌化合物Info
- Publication number
- HK1206031A1 HK1206031A1 HK15106715.4A HK15106715A HK1206031A1 HK 1206031 A1 HK1206031 A1 HK 1206031A1 HK 15106715 A HK15106715 A HK 15106715A HK 1206031 A1 HK1206031 A1 HK 1206031A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- antibacterial compounds
- antibacterial
- compounds
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261614044P | 2012-03-22 | 2012-03-22 | |
PCT/AU2013/000286 WO2013138860A1 (en) | 2012-03-22 | 2013-03-21 | Antibacterial compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1206031A1 true HK1206031A1 (zh) | 2015-12-31 |
Family
ID=49212365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15106715.4A HK1206031A1 (zh) | 2012-03-22 | 2015-07-14 | 抗菌化合物 |
Country Status (6)
Country | Link |
---|---|
US (3) | US9604976B2 (zh) |
EP (1) | EP2828257B1 (zh) |
JP (1) | JP2015514063A (zh) |
CN (1) | CN104302645A (zh) |
HK (1) | HK1206031A1 (zh) |
WO (1) | WO2013138860A1 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012097274A1 (en) | 2011-01-14 | 2012-07-19 | Vertex Pharmaceuticals Incorporation | Process of making gyrase and topoisomerase iv inhibitors |
RU2625305C2 (ru) | 2011-01-14 | 2017-07-13 | Сперо Тринем, Инк. | Твердые формы ингибитора гиразы (r)-1-этил-3-[6-фтор-5[2-(1-гидрокси-1-метил-этил) пиримидин-5-ил]-7-(тетрагидрофуран-2-ил)-1н-бензимидазол-2-ил] мочевины |
AU2012205415B2 (en) | 2011-01-14 | 2017-02-02 | Spero Therapeutics, Inc. | Pyrimidine gyrase and topoisomerase IV inhibitors |
TWI554515B (zh) | 2011-06-20 | 2016-10-21 | 維泰克斯製藥公司 | 旋轉酶(gyrase)及拓樸異構酶抑制劑之磷酸酯 |
US9604976B2 (en) * | 2012-03-22 | 2017-03-28 | Spero Gyrase, Inc. | Antibacterial compounds |
US9572809B2 (en) | 2012-07-18 | 2017-02-21 | Spero Trinem, Inc. | Combination therapy to treat Mycobacterium diseases |
US9018216B2 (en) | 2012-07-18 | 2015-04-28 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof |
CA2938459A1 (en) * | 2014-02-03 | 2015-08-06 | Spero Gyrase, Inc. | Antibacterial compounds |
AU2015342017B2 (en) | 2014-11-03 | 2020-02-06 | Bayer Pharma Aktiengesellschaft | Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof |
US9988367B2 (en) | 2016-05-03 | 2018-06-05 | Bayer Pharma Aktiengesellschaft | Amide-substituted pyridinyltriazole derivatives and uses thereof |
EP3452457B1 (en) | 2016-05-03 | 2020-03-18 | Bayer Pharma Aktiengesellschaft | Oxoalkyl-substituted phenyltriazole derivatives and uses thereof |
US10702525B1 (en) | 2019-09-04 | 2020-07-07 | United Arab Emirates University | Pyrimidine derivatives as anti-diabetic agents |
CN115124544B (zh) * | 2022-07-20 | 2023-06-23 | 四川抗菌素工业研究所金华分所 | 一种螺[四氢呋喃-3,3’-吲哚啉]骨架物及其晶型和其制备方法与用途 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101048381A (zh) * | 2004-09-09 | 2007-10-03 | 中外制药株式会社 | 新型四氢咪唑衍生物及其用途 |
GB0724349D0 (en) * | 2007-12-13 | 2008-01-30 | Prolysis Ltd | Antibacterial agents |
GB0612428D0 (en) * | 2006-06-22 | 2006-08-02 | Prolysis Ltd | Antibacterial agents |
GB0724342D0 (en) | 2007-12-13 | 2008-01-30 | Prolysis Ltd | Anitbacterial compositions |
WO2009147431A1 (en) * | 2008-06-04 | 2009-12-10 | Astrazeneca Ab | Thiazolo [5, 4-b] pyridine and oxazolo [5, 4-b] pyridine derivatives as antibacterial agents |
WO2009156966A1 (en) | 2008-06-25 | 2009-12-30 | Ranbaxy Laboratories Limited | Benzothiazoles and aza-analogues thereof use as antibacterial agents |
WO2010056320A2 (en) * | 2008-11-11 | 2010-05-20 | Tyrogenex, Inc. | Pi3k/mtor kinase inhibitors |
AU2011313820A1 (en) | 2010-10-08 | 2013-04-11 | Biota Europe Ltd | Antibacterial compounds |
EP2794569B1 (en) * | 2011-12-21 | 2017-05-10 | Biota Europe Ltd | Heterocyclic urea compounds |
US9604976B2 (en) * | 2012-03-22 | 2017-03-28 | Spero Gyrase, Inc. | Antibacterial compounds |
-
2013
- 2013-03-21 US US14/384,237 patent/US9604976B2/en not_active Expired - Fee Related
- 2013-03-21 EP EP13764012.4A patent/EP2828257B1/en not_active Not-in-force
- 2013-03-21 US US13/848,118 patent/US8906902B2/en not_active Expired - Fee Related
- 2013-03-21 CN CN201380014971.5A patent/CN104302645A/zh active Pending
- 2013-03-21 WO PCT/AU2013/000286 patent/WO2013138860A1/en active Application Filing
- 2013-03-21 JP JP2015500716A patent/JP2015514063A/ja active Pending
-
2015
- 2015-07-14 HK HK15106715.4A patent/HK1206031A1/zh unknown
-
2017
- 2017-03-27 US US15/470,419 patent/US20170260178A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2015514063A (ja) | 2015-05-18 |
EP2828257A4 (en) | 2015-08-26 |
US20130252938A1 (en) | 2013-09-26 |
US20150329530A1 (en) | 2015-11-19 |
CN104302645A (zh) | 2015-01-21 |
US8906902B2 (en) | 2014-12-09 |
WO2013138860A1 (en) | 2013-09-26 |
US9604976B2 (en) | 2017-03-28 |
US20170260178A1 (en) | 2017-09-14 |
EP2828257A1 (en) | 2015-01-28 |
EP2828257B1 (en) | 2017-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181889T1 (hr) | Spojevi tetrahidropirazolopirimidina | |
HK1245780B (zh) | 咪唑並吡咯烷酮化合物 | |
EP2925129A4 (en) | PRO-NEUROGENIC COMPOUNDS | |
GB201209138D0 (en) | Compounds | |
GB201214750D0 (en) | Compounds | |
GB201215357D0 (en) | Compounds | |
EP2887803A4 (en) | PRO-NEUROGENIC COMPOUNDS | |
HK1206726A1 (zh) | 咪唑並三嗪酮化合物 | |
HK1206031A1 (zh) | 抗菌化合物 | |
GB201204985D0 (en) | Compounds | |
GB201204125D0 (en) | Compounds | |
EP2763539A4 (en) | ANTIBACTERIAL COMPOUNDS | |
HK1211283A1 (zh) | 化合物 | |
GB201209096D0 (en) | Compounds | |
HK1212677A1 (zh) | 新型抗細菌化合物 | |
HK1206356A1 (zh) | -取代的氰基吡唑化合物 | |
GB201219820D0 (en) | Compounds | |
GB201217310D0 (en) | Compounds | |
HK1210954A1 (zh) | 抗細菌化合物 | |
GB201211202D0 (en) | Antimicrobial compounds | |
IL239207A0 (en) | Antibacterial compounds | |
GB201211203D0 (en) | Antimicrobial compounds | |
GB201223429D0 (en) | Compounds | |
GB201220029D0 (en) | Compounds | |
GB201219819D0 (en) | Compounds |